Glass House Brands (GLAS) Profit After Tax (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Profit After Tax of -$17.0 million for Q1 2026, down 4.67% quarter-over-quarter from -$16.2 million in Q4 2025.
Glass House Brands (GLAS) Profit After Tax (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Profit After Tax for 7 consecutive years, with -$17.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax changed N/A year-over-year to -$17.0 million; the TTM figure through Mar 2026 stood at -$36.7 million (changed N/A YoY), while the FY2025 annual figure was -$29.7 million, down 4219.28% from the prior year.
- Profit After Tax eased to -$17.0 million in Q1 2026 per GLAS's latest filing, from -$16.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $38.1 million in Q4 2023 and bottomed at -$20.4 million in Q1 2022.
- Historically, Profit After Tax has averaged $5.1 million across 5 years, with a median of $8.7 million in 2025.
- On a YoY basis, Profit After Tax climbed as much as 296.28% in 2022 and fell as far as 400.87% in 2022.
- Glass House Brands' Profit After Tax stood at $14.4 million in 2022, then jumped by 164.38% to $38.1 million in 2023, then tumbled by 73.66% to $10.0 million in 2024, then sank by 261.85% to -$16.2 million in 2025, then fell by 4.67% to -$17.0 million in 2026.
- Business Quant data shows GLAS's Profit After Tax at -$17.0 million in Q1 2026, -$16.2 million in Q4 2025, and -$12.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Glass House Brands | 831.09 Mn | 812.54 Mn | 15.77 Mn | -6.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.01 Mn |
| Dec 31, 2025 | -16.25 Mn |
| Sep 30, 2025 | -12.19 Mn |
| Jun 30, 2025 | 8.74 Mn |
| Jun 30, 2024 | 10.04 Mn |
| Dec 31, 2023 | 38.12 Mn |
| Sep 30, 2023 | -210,472.00 |
| Jun 30, 2023 | 24.91 Mn |
| Mar 31, 2023 | 34.78 Mn |
| Dec 31, 2022 | 14.42 Mn |
| Sep 30, 2022 | 15.17 Mn |
| Jun 30, 2022 | -14.19 Mn |
| Mar 31, 2022 | -20.41 Mn |
| Dec 31, 2021 | 18.77 Mn |
| Sep 30, 2021 | -7.73 Mn |
| Jun 30, 2021 | 4.72 Mn |
| Mar 31, 2021 | 13.15 Mn |
| Dec 31, 2020 | 4,059.25 Bn |
| Sep 30, 2020 | -3.80 Mn |
| Mar 31, 2020 | -5.14 Mn |